In this article, we will look at the 12 Stocks That Will Make You Rich in 10 Years.
One of the most read (and recommended) books on investing is Benjamin Graham’s The Intelligent Investor. Among many others, long-term investing is a foundational theme in the book. Graham’s entire framework, from the concept of “Mr. Market” to the “margin of safety,” is designed to help investors think in years, not days.
Even Warren Buffett, the legendary investor and former head of Berkshire Hathaway, thinks the long-term investing strategy is a great approach. In a 2023 CNBC interview, Buffett advised, “Buy wonderful companies at fair prices and hold them for the long term.” He argued that long-term investing minimizes transaction costs, reduces emotional decision-making, and allows investors to benefit from compounding. He’s also been quoted as saying, “The stock market is a device for transferring money from the impatient to the patient.”
Many billionaire investors share Buffett’s position. For example, Fidelity Magellan Fund’s Peter Lynch emphasizes that retail investors can succeed by holding growth stocks for the long term. He’s quoted saying, “People who succeed in the stock market accept periodic losses and stay in the game.” David Booth of Dimensional Fund Advisors told Yahoo Finance that investors should stay invested through market noise, focusing on diversified, low-cost portfolios.
A business executive confidently presenting a financial research report to a boardroom.
Our Methodology
To compile our list of the 12 stocks that will make you rich in 10 years, we sought companies with strong long-term growth potential and robust investor interest. We used the search term “stocks with high growth potential for the next decade” and analyzed financial media reports, analyst insights, and various online resources to create an initial pool of over 30 promising stocks. Next, we narrowed the list by identifying the 12 stocks most favored by institutional investors. To do this, we analyzed hedge fund sentiment data from Insider Monkey’s Q1 2025 database, which tracks the holdings of more than 1,000 elite hedge funds. Finally, we ranked the 12 stocks in ascending order based on the number of hedge funds that held positions in them as of Q1 2025.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
Stocks That Will Make You Rich in 10 Years
12. SAP SE (NYSE:SAP)
Number of Hedge Fund Holders: 33
SAP SE (NYSE:SAP) is one of the 12 stocks that will make you rich in 10 years. On June 23, SAP Taulia, a subsidiary of SAP SE, announced a partnership with PayMate, a business-to-business (B2B) payment solutions provider. According to the agreement, PayMate’s payment infrastructure has been made available to SAP Taulia’s customers.
The integration will allow users to access a broader range of payment options, including bank transfers and virtual card payments. For instance, suppliers can now receive virtual card payments directly into their bank accounts without requiring manual intervention. The partnership also enables businesses to leverage their existing credit lines to optimize working capital, streamline supplier payments, and enhance overall financial efficiency.
SAP Taulia stated that businesses will benefit from the improved platform, which will provide greater control and visibility in their financial operations. Additionally, the new platform streamlines payment processes and enhances payment security.
Danielle Weinblatt, Chief Product Officer at SAP Taulia, stated that the partnership provides customers with “future-forward ways to manage supplier payments” and strengthens their ability to offer flexible and efficient solutions across geographies. She emphasized unlocking liquidity trapped in supply chains.
SAP SE (NYSE:SAP) is a German enterprise software company. It develops and sells cloud-based and on-premise solutions that help businesses manage operations like finance, supply chain, HR, and customer experience. Its core products include SAP S/4HANA (ERP), SuccessFactors (HR), Ariba (procurement), Concur (travel and expense), and SAP Analytics Cloud.
11. AstraZeneca PLC (NASDAQ:AZN)
Number of Hedge Fund Holders: 56
AstraZeneca PLC (NASDAQ:AZN) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company announced that the FDA had granted accelerated approval to Datroway for the treatment of adult patients with non-small cell lung cancer (NSCLC).
Datroway is the first and only TROP2-directed antibody-drug conjugate (ADC) approved in the U.S. for lung cancer. The drug is jointly developed and commercialized by AstraZeneca and Daiichi Sankyo. The companies signed a global collaboration agreement in July 2020, valued at up to $6 billion. As part of the agreement, Daiichi Sankyo maintains exclusive rights in Japan, while both companies share responsibilities elsewhere.
The approval followed a Priority Review and Breakthrough Therapy Designation by the FDA, reflecting the drug’s potential to address an unmet medical need. Continued approval may depend on verification of clinical benefit in a confirmatory trial, as is standard for accelerated approvals. Following the approval, AstraZeneca will pay Daiichi Sankyo a $45 million milestone payment for the NSCLC indication, as stipulated in their 2020 collaboration agreement.
AstraZeneca PLC (NASDAQ:AZN) is a global biopharmaceutical company. It discovers, develops, manufactures, and markets prescription medicines across disease areas like oncology, cardiovascular, renal and metabolism, respiratory, immunology, vaccines, and rare diseases. Its leading products include Tagrisso, Imfinzi, Farxiga, Brilinta, Symbicort, and Soliris.
10. Novo Nordisk A/S (NYSE:NVO)
Number of Hedge Fund Holders: 60
Novo Nordisk A/S (NYSE:NVO) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company discontinued its partnership with Hims & Hers concerning selling its weight-loss drug, Wegovy. This decision was made less than two months after the companies had initially announced their collaboration.
According to Novo Nordisk, Hims & Hers failed to adhere to the law prohibiting mass sales of compounded drugs under the “false guise of ‘personalization’.” The company accused its partner of disseminating “deceptive marketing” that risks patient safety and selling “illegitimate, knockoff versions” of Wegovy. Novo Nordisk states that its investigation showed the active pharmaceutical ingredients (APIs) in these knockoff drugs, particularly “semaglutide” from telehealth entities and compounding pharmacies, are manufactured by foreign suppliers in China and were often not inspected by the FDA.
In response, Andrew Dudum, CEO of Hims & Hers, stated on X that the company is “disappointed to see Novo Nordisk management misleading the public.” Dudum alleged that Novo Nordisk’s commercial team “increasingly pressured us to control clinical standards and steer patients to Wegovy regardless of whether it was clinically best for patients.” He asserted that Hims & Hers “refuse[s] to be strong-armed by any pharmaceutical company’s anticompetitive demands that infringe on the independent decision-making of providers and limit patient choice.”
Novo Nordisk A/S (NYSE: NVO) is a Danish healthcare company operating globally. It develops, manufactures, and markets pharmaceutical products for the treatment of chronic diseases, primarily diabetes and obesity. Its well-known products include Ozempic, Wegovy, Rybelsus, and Norditropin.
9. Caterpillar Inc. (NYSE:CAT)
Number of Hedge Fund Holders: 62
Caterpillar Inc. (NYSE:CAT) is one of the 12 stocks that will make you rich in 10 years. On June 20, Bernstein SocGen Group maintained its “Market Perform” rating and $304 price target on Caterpillar (NYSE:CAT) after touring its large engine facility in Indiana. Analysts cited capacity expansion and upcoming growth opportunities as potential profit drivers.
Caterpillar is seen as well-positioned to benefit from rising global energy demand, with strong cash flows and a 55-year dividend streak. Bernstein highlighted opportunities in data center power, distributed systems, and natural gas operations—areas where Caterpillar is expanding through its Solar Turbines division and Titan 350 engine platform.
Caterpillar Inc. (NYSE:CAT) is a global powerhouse in construction and mining machinery. Its operations are organized into three core segments: Construction Industries, Resource Industries, and Financial Products.
8. Linde plc (NASDAQ:LIN)
Number of Hedge Fund Holders: 75
Linde plc (NASDAQ:LIN) is one of the 12 stocks that will make you rich in 10 years. The company announced on June 23 that it has set aside $400 million to construct the largest air separation unit (ASU) in the Mississippi River corridor. The facility will be located on the West Bank of Ascension Parish, Louisiana, at the 17,000-acre RiverPlex MegaPark in Donaldsonville.
The ASU will supply high-purity oxygen and nitrogen to Blue Point Number One. This $4 billion low-carbon ammonia production facility is a joint venture between CF Industries, JERA, and Mitsui & Co. The project aims to produce 1.4 million metric tons of low-carbon ammonia annually.
Linde stated that construction of the ASU is scheduled to begin in 2026, with operations expected to start in 2029. The project is anticipated to create 15 new direct jobs with average annual salaries more than 45% above the Ascension Parish average wage. It will also retain over 100 existing Linde positions across Louisiana and generate an estimated 50 indirect jobs, totaling 65 potential new jobs in the Capital Region.
Linde plc (NASDAQ:LIN) is a global industrial gases and engineering company. It produces and supplies atmospheric gases like oxygen and nitrogen, process gases such as hydrogen and carbon dioxide, and related equipment and technologies. Its products are used in industries including chemicals, healthcare, electronics, food and beverage, metals, and energy.
7. Johnson & Johnson (NYSE:JNJ)
Number of Hedge Fund Holders: 91
Johnson & Johnson (NYSE:JNJ) is one of the 12 stocks that will make you rich in 10 years. On June 23, J&J announced new data from an indirect treatment comparison (ITC) study. The data show that the company’s drug, IMAAVY (nipocalimab-aahu), demonstrated consistent and sustained disease control in patients with generalized myasthenia gravis (gMG) compared to other approved FcRn blockers. The findings were presented at the European Academy of Neurology (EAN) 2025 Congress in Helsinki, Finland.
According to the findings, IMAAVY showed a comparable onset of symptom relief at Week 1. The drug demonstrated consistent and sustained disease control over multiple timepoints up to 24 weeks. More importantly, IMAAVY showed greater or statistically significant improvement in Myasthenia Gravis Activities of Daily Living (MG-ADL) scores compared to the published Phase 3 data of other FcRn blockers.
The drug received FDA approval on April 30, 2025, for adults and pediatric patients aged 12 and older with anti-AChR or anti-MuSK antibody-positive gMG. This makes IMAAVY the first and only FcRn blocker approved for both antibody types, covering ≥90% of antibody-positive gMG patients.
Johnson & Johnson (NYSE:JNJ) is a global healthcare company. It develops, manufactures, and sells pharmaceuticals and medical devices through two main segments: Innovative Medicine and MedTech. Its key pharmaceutical products include Darzalex, Stelara, Tremfya, and Carvykti, while its MedTech offerings span surgical technologies, orthopedics, and vision care.
6. The Progressive Corporation (NYSE:PGR)
Number of Hedge Fund Holders: 91
The Progressive Corporation (NYSE:PGR) is one of the 12 stocks that will make you rich in 10 years. On June 20, Wells Fargo raised its price target for Progressive Corporation from $328.00 to $333.00 while maintaining an “Overweight” rating, signaling continued confidence in the stock’s upside potential.
The firm acknowledged that Progressive’s shares declined following a slowdown in auto policies in force (PIF) growth. However, it viewed the market reaction as excessive, highlighting that the company added a robust 246,000 policies during the month—substantially outperforming the 51,000 vehicle additions reported by Allstate.
The Progressive Corporation (NYSE:PGR) is an American insurance company. It provides personal and commercial auto insurance, home and renters insurance, and specialty lines like motorcycle, RV, and boat coverage. It also offers commercial property, general liability, and workers’ compensation insurance for small businesses.
5. Merck & Co., Inc. (NYSE:MRK)
Number of Hedge Fund Holders: 93
Merck & Co., Inc. (NYSE:MRK) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company shared encouraging results from its Phase 3 HYPERION trial. The study tested a drug called WINREVAIR (sotatercept-csrk) against a placebo, both combined with standard treatment, in adults recently diagnosed with pulmonary arterial hypertension (PAH)—a serious lung condition.
The trial involved around 320 people from different countries. Most participants were already on two background treatments, unlike earlier trials where most were on three. WINREVAIR showed it could significantly slow down the worsening of PAH compared to the placebo. However, the company didn’t release the exact numbers yet, only saying the results were both statistically and medically meaningful.
Merck & Co., Inc. (NYSE:MRK) is a global biopharmaceutical company. It discovers, develops, manufactures, and markets prescription medicines, vaccines, biologic therapies, and animal health products. Its key products include Keytruda (cancer), Gardasil (HPV vaccine), Januvia (diabetes), and Bridion (anesthesia reversal).
4. The Home Depot, Inc. (NYSE:HD)
Number of Hedge Fund Holders: 102
The Home Depot, Inc. (NYSE:HD) is one of the 12 stocks that will make you rich in 10 years. On June 23, TD Cowen reaffirmed its “Buy” rating on Home Depot’s stock. The firm also kept the $470.00 price target. This decision followed reports of the company’s potential acquisition of GMS Inc. (NYSE:GMS), a specialty distributor of building products.
Reports indicate that Home Depot submitted a competing offer to acquire GMS following an initial bid by QXO. According to TD Cowen, the potential GMS acquisition aligns with Home Depot’s strategy to expand its presence in the professional contractor market. The firm noted that Home Depot has done well in previous acquisition attempts. For instance, while the market initially viewed the SRS acquisition skeptically, it has proven “very successful,” demonstrating Home Depot’s ability to integrate and grow acquired businesses.
Nevertheless, TD Cowen expressed a neutral stance on the GMS bid, stating that it would move Home Depot further from its core single-family residential professional business. This could add operational complexity and dilute margins at a price described as “not cheap.” The acquisition could also delay Home Depot’s share buyback program.
The Home Depot, Inc. (NYSE:HD) is the largest home improvement retailer in the U.S. It sells building materials, home improvement products, lawn and garden supplies, and offers installation and tool rental services. Its key product categories include building materials, décor, and hardlines like tools and appliances.
3. Eli Lilly and Company (NYSE:LLY)
Number of Hedge Fund Holders: 119
Eli Lilly and Company (NYSE:LLY) is one of the 12 stocks that will make you rich in 10 years. On June 23, Truist Securities reiterated its “Buy” rating on Eli Lilly stock. The firm also maintained the price target of $1,038.00. Truist’s move followed Eli Lilly’s presentation at the American Diabetes Association (ADA) 85th Annual Meeting.
The rating pertains to Eli Lilly’s oral diabetes drug, orforglipron (OFG), evaluated in the Phase 3 ACHIEVE-1 study for Type 2 diabetes treatment. The ACHIEVE-1 study results were presented at the ADA conference, showcasing orforglipron’s efficacy and safety profile. The trial demonstrated statistically significant reductions in A1C (a long-term blood sugar metric) and body weight compared to placebo, with efficacy increasing at higher doses.
Truist’s analysis was informed by attending the orforglipron presentation, gathering feedback from KOLs at the ADA conference, and participating in Eli Lilly’s investor event, where management provided clarity to alleviate safety concerns. The firm noted that longer-term data are required to further strengthen orforglipron’s safety profile, particularly for chronic use in diabetes and potential obesity indications.
Eli Lilly and Company (NYSE:LLY) is an American global biopharmaceutical company. The company discovers, develops, and markets prescription medicines for diabetes, obesity, cancer, immunological disorders, and neurological diseases. Its key products include Mounjaro, Zepbound, Trulicity, Verzenio, Taltz, and Jardiance.
2. Salesforce, Inc. (NYSE:CRM)
Number of Hedge Fund Holders: 140
Salesforce, Inc. (NYSE:CRM) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company announced an enhanced collaboration with PayPal (NASDAQ:PYPL) through the Salesforce Agentforce platform. Specifically, users can now integrate PayPal as a featured Model Context Protocol (MCP) Server on Agentforce’s AgentExchange platform.
The partnership enables Agentforce users to seamlessly integrate PayPal’s full suite of commerce tools to create AI-powered agents for streamlined business operations. PayPal’s designation as an MCP Server allows Agentforce’s AI agents to connect with the firm’s commerce tools without requiring custom code.
The partnership expansion was announced alongside the launch of Agentforce 3. Agentforce 3 is a significant upgrade to Salesforce’s AI agent development platform, which includes a new Command Center for monitoring AI agents and a 233% increase in AI agent usage over six months. Its MCP support extends to over 30 partners, including AWS, Google Cloud, Stripe, and Cisco Systems.
Salesforce, Inc. (NYSE:CRM) is an American enterprise software company. It provides cloud-based customer relationship management (CRM) solutions that help businesses manage sales, service, marketing, commerce, and analytics. Its core products include Sales Cloud, Service Cloud, Marketing Cloud, Commerce Cloud, and the Salesforce Platform, which integrates AI and automation tools like Agentforce.
1. Amazon.com, Inc. (NASDAQ:AMZN)
Number of Hedge Fund Holders: 328
Amazon.com, Inc. (NASDAQ:AMZN) is one of the 12 stocks that will make you rich in 10 years. On June 24, the company revealed a £40 billion ($54 billion) investment plan in the United Kingdom over the next three years (2025–2027) to expand its operations and infrastructure.
The investment includes £8 billion ($10.9 billion) previously pledged by Amazon Web Services (AWS) in September 2024. This amount was for building, operating, and maintaining data centers in the UK from 2024 to 2028. The additional funds will support the construction of four new fulfillment centers. Two facilities in the East Midlands are scheduled to open in 2027, and previously announced sites in Hull (2025) and Northampton (2026). Each fulfillment center is expected to create approximately 2,000 jobs.
Amazon said that additional investments will cover new delivery stations across the UK, upgrades and expansions to the company’s existing network of over 100 operational facilities. The tech giant also stated that it expects the investment to contribute £38 billion ($51.7 billion) to the UK’s GDP over the period in focus.
Amazon.com, Inc. (NASDAQ:AMZN) is a global technology and e-commerce company. It operates online and physical stores. The company offers many products, including electronics, apparel, groceries, and media. Amazon also provides cloud computing services through AWS, and offers devices like Kindle, Echo, and Fire TV.
While we acknowledge the potential of AMZN to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than AMZN and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: 10 Best Value Penny Stocks to Buy According to Analysts and 12 Best Augmented Reality Stocks to Buy According to Analysts.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email below.
